Citable company snapshot
Moderna, Inc.'s latest SEC-sourced 2026-03-31 period shows $389.00M in revenue and $-1.34B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:RevenueFromContractWithCustomerExcludingAssessedTax | Mar 31, 2026 | $389.00M | $678.00M | -42.6% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $-1.39B | $-857.00M | -62.0% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $-1.34B | $-826.00M | -62.6% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $-630.00M | $930.00M | -167.7% |
| Free Cash Flow (computed) | Mar 31, 2026 | $-692.00M | $891.00M | -177.7% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed May 1, 2026; accession 0001682852-26-000060.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
